LULU vs TMO: Which Is the Better Buy?
Side-by-side comparison of Lululemon Athletica Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Lululemon Athletica Inc. · Consumer Cyclical
$128.98
+307.7% upside to fair value
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
LULU has more upside to fair value
(+307.7%).
LULU trades at a lower forward P/E
(9.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LULU |
TMO |
| Current Price |
$128.98 |
$462.60 |
| Fair Value Estimate |
$525.85 |
$509.20 |
| Upside to Fair Value |
+307.7%
|
+10.1%
|
| Market Cap |
$15.1B |
$171.9B |
| Forward P/E |
9.7x
|
25.1x
|
| EV / EBITDA |
5.6x
|
19.0x
|
| Price / Sales |
1.4x
|
3.8x
|
| Price / FCF |
16.4x
|
25.5x
|
| Revenue Growth YoY |
+0.8%
|
+6.2%
|
| Gross Margin |
56.6%
|
39.4%
|
| Operating Margin |
19.8%
|
17.8%
|
| Return on Equity |
34.8%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.09%
|
3.92%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Lululemon Athletica Inc. is a premium athletic apparel retailer operating primarily in the consumer cyclical sector with a focus on apparel retail. The company has a strong brand and historically high profitability with a gross margin of 56.6% and ROE of 34.8%, but it faces significant near-term challenges including earnings pressure with a 21.6% decline in earnings in the most recent quarter and…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
LULU |
TMO |
| Zone Low |
$394.39 |
$381.90 |
| Zone High |
$446.97 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|